Context Therapeutics Inc. CNTX
0.19 USD -0.02 (-7.42%)
Nov 5, 2026, 3:59 PM EST
0.1862 Day range 0.2101
0.1862 52-week range 3.62
- YTD
- -87.18%
- 1 year
- -83.33%
Financial health
Altman Z-Score
-5.57 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B3 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 4
Valuation
P/E -3.9×
FY 2019 5y median -0.8× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 2.3×
FY 2019 5y median 0.6× FY 2025
P/FCF -5.3×
FY 2019 5y median -0.9× FY 2025
EV/EBITDA -2.1×
FY 2019 5y median 1.2× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -18.9%
FY 2019 5y median -116.7% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -59.7%
FY 2019 5y median -42.7% FY 2025
ROIC -65.5%
FY 2019 5y median -44.2% FY 2025
ROA -52.7%
FY 2019 5y median -39.1% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income -32.7%
FY 2019 FY 2025
EPS (diluted) 17.4%
FY 2019 FY 2025
Free Cash Flow 9.9%
FY 2019 FY 2025
Financial Health
Current Ratio 8.5×
FY 2019 5y median 11.8× FY 2025
Quick Ratio 8.5×
FY 2019 5y median 11.8× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 1.8×
FY 2019 5y median 2.4× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31